Melanotan 2 is a synthetic melanocortin analog the body answers like sunlight.

Before the details

Melanotan 2 is a lab-made copy of a natural body signal that tells skin to make more of its dark pigment. People inject it to get a deep tan with little or no sun. It works: the color comes in within days. But the same signal does far more than tan. It dulls appetite, it triggers sudden erections in men, and it makes existing moles darken — sometimes it brings new moles out within a day. The studies behind it are tiny. Only a handful of people have ever taken it in a controlled trial, and no regulator anywhere has approved it for anything. What sits beside the tan is a record of real harm — case reports of kidney injury, of muscle breakdown, of prolonged painful erections, of melanoma. This site is a reading of that published record, kept grave and exact. What people report — the upsides and the downsides both — is laid out plainly on the Melanotan 2 effects page.

The myth, told from the receptor

Melanotan 2 (Melanotan II, MT-2, MT-II) is a cyclic, truncated, D-Phe-substituted analog of alpha-melanocyte-stimulating hormone (alpha-MSH) — the natural thirteen-amino-acid messenger the body uses to set its pigment ^[1][8]. Hruby and Hadley designed it at the University of Arizona in the late 1980s to be superpotent and enzymatically durable: a ring closed by a lactam bridge (an internal chemical clasp) so that it survives where the linear hormone is quickly torn apart ^[7][1].

It is a non-selective melanocortin agonist — it reaches every one of the five melanocortin receptors (MC1R through MC5R) ^[8]. On the pigment cell, it raises cyclic AMP (a relay molecule inside the cell) and drives the cascade that shifts skin and hair toward the dark, more protective eumelanin, without any UV light ^[8]. That is the luminous promise. The same key turns other locks: appetite in the hypothalamus, the erectile circuitry of the brain. The whole arc — what it is, how it works, what it has shown, and what it has cost — is the subject here. Start with what is melanotan 2.

What the record actually holds

The human record is thin, and the site does not pretend otherwise. In a single-blind, placebo-controlled pilot Phase I study, three healthy men received subcutaneous Melanotan 2 every other weekday; pigmentation of the face, upper body, and buttocks increased in two of three subjects after only five low doses, alongside spontaneous erections lasting one to five hours and mild nausea ^[1]. A separate double-blind crossover study in ten men with psychogenic erectile dysfunction found clinically apparent erections in eight of ten, with mean rigidity duration of 38.0 minutes versus 3.0 minutes on placebo ^[2]. These doses are reported as study-design facts, not as anything a reader should attempt — Melanotan 2 is not approved for human use anywhere.

That is nearly the whole of the controlled human evidence. No Phase II or Phase III trial has ever been completed for Melanotan 2 itself ^[1]. The deeper mechanism work — appetite, energy, erectile signaling, pigment — lives almost entirely in rodents ^[5][8].

The shadow

Every bargain has its cost, and Melanotan 2's is written in case reports. A nephrology review described renal infarction — a sudden loss of blood supply to the kidney — most likely attributable to Melanotan 2, and noted that rhabdomyolysis (severe muscle breakdown) and renal failure had been described before ^[4]. Priapism, a prolonged and painful erection that is a urological emergency, recurs across reports ^[17]. And because the peptide rouses melanocytes everywhere, users and clinicians repeatedly document moles that darken, change, or erupt anew — with melanoma reported in melanotan users ^[12].

The product itself is unregulated: forensic analyses of vials sold online find inaccurate labeling and variable content ^[14]. A buyer cannot know what is in the vial. The honest account of these harms — what people report, and what the literature has cited — is the heart of the Melanotan 2 effects page.